News

Traditionally within the purview of rheumatology, gout can appropriately be managed by nephrologists for patients with ...
since the majority of cases of gout are managed in primary or acute care settings,17,18 where synovial fluid aspiration and polarising microscopy are not commonly performed. Additionally, the existing ...
Gout was defined as recurrent acute episodes of joint inflammation associated with sustained (>1 year) hyperuricaemia (>0.41 mmol/L) and a remission of gout flares during follow-up after adequate ...
ANI Pharmaceuticals has commenced a Phase IV trial to compare two dosage levels of Purified Cortrophin Gel for acute gout ...
ANI Pharma initiates phase 4 trial of purified Cortrophin Gel to treat acute gout flares: Princeton, New Jersey Friday, May 23, 2025, 14:00 Hrs [IST] ANI Pharmaceuticals, Inc., a ...
Purified Cortrophin Gel is the only ACTH therapy approved by the FDA for the treatment of acute gout flares Trial to be ...
Standard treatments for gout, hyperuricaemia, flare prophylaxis, or pain had been ineffective ... hsCRP levels significantly decreased with treatment. This acute phase reactant change is consistent ...
In fact, controversies persist regarding mechanisms that determine the transition from the initial trigger to myocardial inflammation and from acute myocardial damage to chronic ventricular ...
Acute myeloid leukemia (AML) can cause many different signs and symptoms. Some are more common with certain subtypes of AML. More often these symptoms are caused by something other than leukemia. But ...
Men with gout and obesity receiving febuxostat-based urate-lowering therapy were less likely to achieve serum urate targets and more frequently experienced disease flares. Recent study results ...
The sun unleashed a strong X1.2 solar flare on Tuesday, May 13, within the region on the sun's western limb, as scientists continue to monitor the possibilities of coronal mass ejections ...
which recommends against using pegloticase as the first-line therapy and in patients with infrequent gout flares (<2 flares/year).4 Among the initiators of pegloticase from both datasets, the median ...